Coya Therapeutics Has Been Granted U.S. FDA Fast Track Designation for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/27/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. DRI
8. RKLB
9. SPCX
10. NKE

Go back to Coya Therapeutics Has Been Granted U.S. FDA Fast Track Designation for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
(NASDAQ: COYA) Delayed: 5.50 +0.37 (7.21%)
Previous Close $5.13    52 Week High $ 
Open $5.20    52 Week Low $ 
Day High $5.50    P/E N/A 
Day Low $5.00    EPS $ 
Volume 249,386